$7.95 0.09 (+1.15%)
11/24/2009 4:00 PM

PDL BioPharma, Inc. (PDLI)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

Featured Broker Partners